Sensitizing versus immunizing properties of inactivated measles vaccine
Wilson, S.; Aprile, M.A.
Progress in Immunobiological Standardization 4: 657-660
1970
ISSN/ISBN: 0079-6344 PMID: 4991597 Document Number: 24689
Document emailed within 1 workday
Related Documents
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781Vasil'eva, O.A.; Peretrukhina, A.T.; Meniavtseva, T.A. 1977: Sensitizing properties of smallpox vaccine Voprosy Virusologii 3: 324-326
Fowlkes, A.; Witte, D.; Beeler, J.; Audet, S.; Garcia, P.; Curns, A.; Yang, C.; Fudzulani, R.; Broadhead, R.; Bellini, W.J.; Cutts, F.; Helfand, R.F. 2011: Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi Journal of Infectious Diseases 204(Suppl 1): S149-S157
Vasil'eva, G.A.; Slatin, E.A. 1983: Inoculation properties of live combined vaccine against measles and mumps Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 70-75
Tikhonova, N.T.; Khrometskaia, T.M.; Livanova, L.V.; Poliakova, T.A.; Azarova, S.A. 1978: Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles Voprosy Virusologii 3: 322-327
Martins, C.; Garly, M-Lill.; Bale, C.; Rodrigues, A.; Benn, C.S.; Whittle, H.; Aaby, P. 2013: Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines Vaccine 31(48): 5766-5771
Makino, S.; Sasaki, K.; Nakamura, N.; Nakagawa, M.; Nakajima, S. 1974: Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine Kitasato Archives of Experimental Medicine 47(1-2): 13-21
Wennerås, C.; Czerkinsky, C.; Svennerholm, A.M. 1995: Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine Advances in Experimental Medicine and Biology 371b: 1641-1644
Murphey-Corb, M.; Martin, L.N.; Davison-Fairburn, B.; Montelaro, R.C.; Miller, M.; West, M.; Ohkawa, S.; Baskin, G.B.; Zhang, J.Y.; Putney, S. 1990: A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys Developments in Biological Standardization 72: 273-285
Techasena, W.; Sriprasert, P.; Pattamadilok, S.; Wongwacharapipoon, P. 2007: Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months Journal of the Medical Association of Thailand 90(1): 106-112
Modlin, J.F.; Jabbour, J.T.; Witte, J.J.; Halsey, N.A. 1977: Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis Pediatrics 59(4): 505-512
Kanbur, N.Oksüz.; Derman, O.; Kutluk, T. 2005: Measles seroprevalence of an adolescent population vaccinated with a single dose of measles vaccine before their first birthday International Journal of Adolescent Medicine and Health 17(4): 337-341
Markowitz, L.E.; Nieburg, P. 1991: The burden of acute respiratory infection due to measles in developing countries and the potential impact of measles vaccine Reviews of Infectious Diseases 13(Suppl): S555-S561
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Hutchins, S.S.; Escolan, J.; Markowitz, L.E.; Hawkins, C.; Kimbler, A.; Morgan, R.A.; Preblud, S.R.; Orenstein, W.A. 1989: Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine Pediatrics 83(3): 369-374
Shahzad, A.; Köhler, G. 2009: Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program Vaccine 27(39): 5293-5294
Chotpitayasunondh, T.; Sohn, Y.M.; Yoksan, S.; Min, J.; Ohrr, H. 2011: Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand Journal of the Medical Association of Thailand 94(Suppl 3): S195-S203
Bahl, R.; Kumar, R.; Bhandari, N.; Kant, S.; Srivastava, R.; Bhan, M.K. 1999: Vitamin a administered with measles vaccine to nine-month-old infants does not reduce vaccine immunogenicity Journal of Nutrition 129(8): 1569-1573
Domorázková, E.; Drevo, M.; Burian, V.; Burianová-Vysoká, B.; Janotová, J.; Kratochvílová, M.; Kríz, J.; Vodicková, M.; Kyselová, M. 1973: Use of live measles vaccine in the 3d injection of basic DTPA vaccine (Diphtheria, Tetanus, Pertussia Antitoxin) Ceskoslovenska Pediatrie 28(3): 129-130
Trotter, A.C.; Stone, B.D.; Laszlo, D.J.; Georgitis, J.W. 1994: Measles, mumps, rubella vaccine administration in egg-sensitive children: systemic reactions during vaccine desensitization Annals of Allergy 72(1): 25-28